Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 30

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

307

HTML

2286

Figures (1-2)

186

Tables (1-4)

215

Sum=2994

Aug 14, 2005 (publication date) through Nov 13, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Aug 14, 2005; 11(30): 4655-4660
Published online Aug 14, 2005. doi: 10.3748/wjg.v11.i30.4655

Table 2 Levels of serum free IGF-II and AFP in patients with chronic liver diseases

^bP<0.01 vs the chronic hepatitis group or the liver cirrhosis group. HCC: hepatocellular carcinoma; LC: liver cirrhosis; CH: chronic hepatitis.

Citation: Dong ZZ, Yao DF, Yao DB, Wu XH, Wu W, Qiu LW, Jiang DR, Zhu JH, Meng XY. Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma. World J Gastroenterol 2005; 11(30): 4655-4660
URL: https://www.wjgnet.com/1007-9327/full/v11/i30/4655.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i30.4655